NSE: BRITANNIA· FMCGCyclical · Aug 26Large cap
Britannia Industries
Cleanest GST beneficiary
- Last close
- ₹4,835.00
- 29 Sept 2026 · reference
- 1D · 1M
- −1.6% · −8.9%
- price-only
- Weight
- 2.0%
- 31 Jul 2026 · Aug rank 21
- Thesis review
- 8 Sep 2026
- Why We Own, p34
Map
What must happen → what could break it → what we watch
Catalysts · 3
- Q2FY27 results (early Nov-2026): management guided a return to double-digit topline growth 'by the fag end of Q2FY27'; 1.5-2% price hikes flowing through should lift margin.C1
- Festive quarter (Oct-Dec 2026) with full GST 2.0 base effect and state cash-transfer disbursements; NIQ data for Jul-Sep 2026 (due Nov-2026) will show whether food volume growth re-accelerates.C2
- Board decisions on capital allocation (dairy/adjacency capex, possible special dividend given 84% payout and Rs 5,100 cr net worth) and PLI incentive recognition (none booked in FY26/Q1FY27).C3
Material risks · 3
- Input-cost inflation (LPG/CNG, palm oil, sugar, packaging from crude spikes and West Asia conflict) with only ~50% mitigated by pricing in Q1FY27 - EBITDA margin (16.8%) is below the 18-19% of FY24-FY26 and PL cut FY27/28 EPS 4-5%.R1
- Competitive dual-pricing disruption in the 60-65% mass segment (competitors kept old MRPs post-GST) and Oman/UAE production shift cost ~1-1.5% of sales; double-digit topline not expected until end-Q2FY27.R2
- Slow structural growth: 5-yr sales CAGR 7.8% and profit CAGR 6% (screener); at 47x trailing and 23.8x book any volume relapse compresses the multiple further (stock -17% YoY).R3
Live monitors
- Valuation vs approved targetNo target stated
- Latest reported quarterQ Jun-26
- Results-driven thresholdsAwaiting approved numbers
Catalysts and risks are the approved one-pager text in full; the register below adds owners and review dates. Monitors read from the price and fundamentals feeds.
Risks as a decision framework
Material risks
| # | Risk (approved text) | Owner · next review |
|---|---|---|
| 01 | Input-cost inflation (LPG/CNG, palm oil, sugar, packaging from crude spikes and West Asia conflict) with only ~50% mitigated by pricing in Q1FY27 - EBITDA margin (16.8%) is below the 18-19% of FY24-FY26 and PL cut FY27/28 EPS 4-5%. | Research · post 2QFY27 |
| 02 | Competitive dual-pricing disruption in the 60-65% mass segment (competitors kept old MRPs post-GST) and Oman/UAE production shift cost ~1-1.5% of sales; double-digit topline not expected until end-Q2FY27. | Research · post 2QFY27 |
| 03 | Slow structural growth: 5-yr sales CAGR 7.8% and profit CAGR 6% (screener); at 47x trailing and 23.8x book any volume relapse compresses the multiple further (stock -17% YoY). | Research · post 2QFY27 |
Exposure mechanism, impact and mitigants are as written in the book. Leading indicators and numeric triggers not stated in the approved text remain research tasks rather than being invented.
Catalysts
Observable events
- 01Q2FY27 results (early Nov-2026): management guided a return to double-digit topline growth 'by the fag end of Q2FY27'; 1.5-2% price hikes flowing through should lift margin.
- 02Festive quarter (Oct-Dec 2026) with full GST 2.0 base effect and state cash-transfer disbursements; NIQ data for Jul-Sep 2026 (due Nov-2026) will show whether food volume growth re-accelerates.
- 03Board decisions on capital allocation (dairy/adjacency capex, possible special dividend given 84% payout and Rs 5,100 cr net worth) and PLI incentive recognition (none booked in FY26/Q1FY27).
Monitors
Live monitors from available data
- ClearValuation exceeding the approved range: reference close 4,835 vs base target not stated.
- DataLatest reported quarter in fundamentals: Q Jun-26. Results-driven monitors (growth below thesis threshold, margin, credit cost) need approved numeric thresholds; none in the book.
- DataInput-cost and capital-allocation monitors require licensed commodity/filings feeds — not configured.